These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24577950)

  • 1. PET/MRI and PET/CT in follow-up of head and neck cancer patients.
    Queiroz MA; Hüllner M; Kuhn F; Huber G; Meerwein C; Kollias S; von Schulthess G; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1066-75. PubMed ID: 24577950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography.
    Morbelli S; Conzi R; Campus C; Cittadini G; Bossert I; Massollo M; Fornarini G; Calamia I; Marini C; Fiz F; Ghersi C; Derchi LE; Sambuceti G
    Cancer Imaging; 2014 Apr; 14(1):10. PubMed ID: 25609564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck cancer surveillance: The value of computed tomography and clinical exam.
    Farsi S; Gardner JR; King D; Sunde J; Moreno M; Vural E
    Am J Otolaryngol; 2024 Aug; 45(6):104469. PubMed ID: 39106677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review.
    Neilio JM; Ginat DT
    Diagnostics (Basel); 2024 Aug; 14(15):. PubMed ID: 39125542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.
    Queiroz MA; Hüllner M; Kuhn F; Huber G; Meerwein C; Kollias S; von Schulthess G; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2212-21. PubMed ID: 25091219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of PET/MRI: current status and future perspectives.
    Nensa F; Beiderwellen K; Heusch P; Wetter A
    Diagn Interv Radiol; 2014; 20(5):438-47. PubMed ID: 25010371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT and PET/MRI in head and neck malignancy.
    Szyszko TA; Cook GJR
    Clin Radiol; 2018 Jan; 73(1):60-69. PubMed ID: 29029767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous PET/MRI vs PET/CT in oncology. A systematic review.
    Riola-Parada C; García-Cañamaque L; Pérez-Dueñas V; Garcerant-Tafur M; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):306-12. PubMed ID: 27424217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
    Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
    AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
    Sanli Y; Zukotynski K; Mittra E; Chen DL; Nadel H; Niederkohr RD; Subramaniam RM
    Clin Nucl Med; 2018 Dec; 43(12):e439-e452. PubMed ID: 30394934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of PET/MRI in radiotherapy.
    Yan Q; Yan X; Yang X; Li S; Song J
    Insights Imaging; 2024 Feb; 15(1):63. PubMed ID: 38411742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
    Veit-Haibach P; Ahlström H; Boellaard R; Delgado Bolton RC; Hesse S; Hope T; Huellner MW; Iagaru A; Johnson GB; Kjaer A; Law I; Metser U; Quick HH; Sattler B; Umutlu L; Zaharchuk G; Herrmann K
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3513-3537. PubMed ID: 37624384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of
    Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
    Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of
    Li H; Chen X; Zhang Y; Wang K; Gao Z
    Cancer Manag Res; 2021; 13():2869-2876. PubMed ID: 33824601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Pace L; Nicolai E; Cavaliere C; Basso L; Garbino N; Spinato G; Salvatore M
    Ann Nucl Med; 2021 Apr; 35(4):479-484. PubMed ID: 33575927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
    Morand GB; Broglie MA; Schumann P; Huellner MW; Rupp NJ
    Front Oncol; 2020; 10():1670. PubMed ID: 32984043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous
    Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter- and Intrareader Agreement of NI-RADS in the Interpretation of Surveillance Contrast-Enhanced CT after Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Elsholtz FHJ; Ro SR; Shnayien S; Erxleben C; Bauknecht HC; Lenk J; Schaafs LA; Hamm B; Niehues SM
    AJNR Am J Neuroradiol; 2020 May; 41(5):859-865. PubMed ID: 32327436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.